Document is current
Any future updates will be listed below
-
Authors
Rajendran Nair, Deepthi S.
Seiler, Magdalene J.
Martinez-Camarillo, Juan Carlos
Xue, Yuntian
Sharma, Ruchi
Bharti, Kapil
Humayun, Mark S.
Thomas, Biju B. https://orcid.org/0000-0001-8851-5241
-
Funding
Funding for this research was provided by:
National Institute of Health (EY031144, R01 EY031834-01A1)
National Eye Institute (EY-017337)
California Institute of Regenerative Medicine (DISC1-09912)
- License Information
-
More Information
Article History
Received: 28 October 2023
Accepted: 5 March 2025
First Online: 21 May 2025
Declarations
:
: All experiments were approved by the University of Southern California Institutional Animal Care and Use Committee (IACUC, Protocol No. 21303) and were performed following the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals and the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research.
: Not applicable.
: Mark S. Humayun is an investor, a consultant, and a board member of Regenerative Patch Technologies (RPT) and holds an RPT patent. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declare that they have no competing interests.
